在质母细胞瘤中孤立限制扩散:发病率,进展和生存影响
Jai Shankar1, Nikunj Patil2, Marco Ayroso2
1University of Manitoba, Winnipeg, Canada. shivajai1@gmail.com.
Neuroradiology
|July 8, 2025
概括
在21%的质母细胞瘤患者中发现了孤立限制扩散 (IRD),与较差的生存率有关. 许多IRD焦点最终在随访MRI扫描上显示了对比度增强.
科学领域:
- 神经瘤学神经瘤学
- 放射学 放射学是一门学科.
- 医学成像医学成像
背景情况:
- 质母细胞瘤 (GB) 是最具攻击性的原发性脑瘤.
- 孤立限制扩散 (IRD) 是一种特定的MRI发现.
- IRD被定义为在没有立即对比度增强的情况下在增强瘤区域之外的受限扩散.
研究的目的:
- 为了确定质母细胞瘤患者中IRD的发病率.
- 评估IRD焦点在后续成像中增强的速度.
- 分析IRD对患者生存模式的影响.
主要方法:
- 对疑似质母细胞瘤的成年患者进行前性试点队列研究.
- 在初始脑部MRI上对IRD进行查,由两位经验丰富的放射科医生进行.
- 使用考克斯回归和卡普兰-梅尔曲线进行生存分析.
主要成果:
- 52名患者中有21%的患者 (11/52) 呈现了IRD焦点.
- 在IRD诊断方面,公平的评价者间可靠性 (kappa = 0.29).
- 64%的IRD焦点在后续成像中显示出增强 (中位数为110天).
- 患有IRD焦点的患者的生存率显著降低 (p=0.035).
结论:
- 在21%的质母细胞瘤病例中存在IRD.
- 大多数 (64%) 的IRD重点随着时间的推移而增强.
- IRD的存在与质母细胞瘤患者的生存时间缩短有关.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


